Medical Marijuana and Hemp News
Medical Marijuana and Hemp News
U.S. Congress Navigates Dual Cannabis Policy Shifts Affecting Industrial Hemp and Marijuana Rescheduling
Explore how U.S. Congressional actions are impacting industrial hemp businesses and the proposed marijuana rescheduling, creating market uncertainty for o…
US Justice Department Reclassifies Medical Cannabis to Schedule III: Implications for Research and Business
Explore the US Justice Department's reclassification of medical cannabis to Schedule III, impacting tax breaks for businesses and easing research restrict…
Industrial Hemp Advocates Discuss Policy, Market Development, and CBD Regulation
HempToday's Kehrt Reyher discusses industrial hemp policy, CBD regulation, and market development. Insights cover legislative efforts, construction applic…
Texas Judge Extends Pause on Smokable Hemp Ban, Citing Irreparable Harm to Industry
A Travis County district judge has extended a temporary injunction, allowing Texas shops to continue selling smokable hemp products until July 27. Learn h…
U.S. House Passes Farm Bill, Omitting Protections for Hemp-Derived Cannabinoid Industry
The U.S. House passed the Farm Bill, leaving federal rules for hemp-derived cannabinoids unchanged. Learn how this impacts the multi-billion-dollar indust…
Texas Voters Show Overwhelming Support for Medical Cannabis Reforms, Poll Indicates
A new poll reveals 75% of Texas voters support medical cannabis reforms, despite low awareness of the state's Compassionate Use Program. Learn about recen…
DEA Assigns New Drug Code to Hexahydrocannabinol (HHC), Reaffirming Schedule I Status
The DEA clarifies hexahydrocannabinol (HHC) is a federally illegal Schedule I substance, assigning it a new drug code. This synthetic cannabinoid does not…
Texas Industrial Hemp Industry Challenges State Ban on Smokable Products and Increased Licensing Fees
Texas industrial hemp businesses are challenging state regulations banning smokable products and increasing licensing fees. Learn how these proposed rules…
CAURD Inc. Outlines Plan to Stabilize New York’s Equity Cannabis Market
CAURD Inc. outlined a three-point plan to stabilize New York's equity cannabis market. This advocacy aims to refine cannabis policy and ensure market viab…
Potential US Federal Medical Cannabis Reclassification Could Reshape Market Dynamics for Marketers and Industry
Explore how potential US federal medical cannabis reclassification could impact market dynamics, regulatory frameworks, and commercialisation strategies f…
